Founders and Visionaries of CLINAM: Patrick Hunziker and Beat Löffler Founding CLINAM Foundation Initiating International Society of Nanomedicine Creating the European Journal of Nanomedicine (now integrated into the Precision Nanomedicine Journal ) Dr. med. h.c. Beat Löffler, MA
Co-founder of CLINAM Foundation and Conference Series. CEO of CLINAM Foundation; Past secretary General of the International Society for Nanomedicine; Organizer of the CLINAM Summit. Key Contributions:
Architect of the annual CLINAM Summit and its international network
Responsible for programme content, organizational leadership, and dissemination
Strategic developer of European and global nanomedicine platforms
Advocate for clinician involvement and cross-disciplinary collaboration
A driver behind the creation of major European research projects
Prof. Dr. med. Patrick Hunziker (CLINAM Profile) Co-founder of CLINAM Foundation and CLINAM Conferences Chief Scientific Officer (CSO), of CLINAM Foundation and Scientific Chair of CLINAM ; President of the International Society for Nanomedicine; Deputy Chief of Intensive Care, University Hospital Basel. Key Contributions:
Shaping the scientific vision and contributing to the quality of CLINAM Summits
Leading the CLINAM Lab and Swissnano group
Advancing translational nanomedicine and clinical research
Instrumental in founding the European and International Societies for Nanomedicine
Major force in integrating clinicians into nanomedicine innovation
A few of the many major scientific figures and field leaders at CLINAM (also see Nobel laureates below)
Nobel Laureates Who Have contributed to the field and presented at CLINAM including Nobel Prize Year and Field, presenting at CLINAM in specific years.
Werner Arber 1978 Medicine. Discovery of restriction enzymes 2011, 2012, 2013
Aaron Ciechanover 2004 Chemistry. Ubiquitin-mediated protein degradation 2016, 2018
Jean-Marie Lehn 1987 Chemistry. Supramolecular chemistry 2017, 2018
Ada Yonath 2009 Chemistry. Ribosome structure, antibiotics 2015, 2022, 2023
Scientific impact: Presenters include the most cited and influential minds in nanomedicine, drug delivery, and translational science.
Foundational leadership: Beat Löffler and Patrick Hunziker have shaped the field’s global dialogue, uniting clinicians, researchers, industry, and regulators for over 15 years.
Interdisciplinary reach: CLINAM a neutral, nonprofit platform accelerating innovation and clinical translation in nanomedicine.
Nobel laureate participation at nearly every summit, spanning chemistry, physics, and medicine, deepening and widening the impact of the field.
CLINAM's Role in Global Convergence of Regulatory Science and Education The CLINAM (European and Global Summit for Clinical Nanomedicine) Summits have significantly influenced the global regulatory science landscape of nanomedicine. Here is a concise overview of their key contributions:(ResearchGate)
Global Regulatory Convergence: CLINAM Summits have provided a unique platform where regulatory authorities from all continents convene annually to discuss the needs of stakeholders in nanomedicine. This has facilitated global regulatory convergence and harmonization efforts in the field. (projects.leitat.org)
Catalyst for Regulatory Framework Development: The Summits have played a pivotal role in initiating discussions and collaborations that have led to the development of regulatory frameworks for nanomedicine, addressing the unique challenges posed by nanotechnology-enabled health products. (PMC)
Promotion of Interdisciplinary Collaboration: By bringing together scientists, clinicians, industry representatives, and regulators, CLINAM has fostered interdisciplinary collaboration essential for the advancement of regulatory science in nanomedicine.
Educational Impact: The Summits have served as educational platforms, disseminating knowledge on the latest developments in nanomedicine and its regulatory aspects, thus contributing to the capacity building of stakeholders worldwide.
Influence on Policy and Standards: Discussions and outcomes from CLINAM Summits have informed policy-making and the establishment of standards, influencing the regulatory landscape of nanomedicine globally. (PMC)
For more detailed information, you can visit the official CLINAM website: https://clinam.org/